Free Trial

Reports on a trial of Moderna's Covid-19......>

FOREX
FOREX: Reports on a trial of Moderna's Covid-19 vaccine, which produced
antibodies for coronavirus in all participants of the experiment, set the tone
of early Asia-Pac trade. The news has inspired risk-on flows, albeit they may
have been limited by caveats surrounding the trial, such as small sample size
and severe side-effects reported by some patients.
- Safe haven FX have lost ground in reaction to renewed risk appetite, with USD,
JPY & CHF leading losses in G10 FX space. Commodity-tied currencies have firmed
up, with AUD/USD having a look above key resistance from Jul 9 high ($0.7001).
- KRW picked up a bid at the reopen of onshore trade, as aforementioned news re:
Covid-19 vaccine has conspired with an unexpected drop in South Korea's
unemployment rate to support the risk-sensitive currency.
- USD/CNH slid under the CNH7.0000 figure and is trying to consolidate below
that level as we type. The daily PBoC fix is due shortly.
- Monetary policy decisions are due from the BoJ & the BoC today. Coming up on
the data front we have UK CPI, U.S. industrial output. Speaker slate features
BoE's Tenreyro & Fed's Harker.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.